Investing.com -- In a surprising turn of events, Hilary Perkins, the chief counsel for the U.S. Food and Drug Administration (FDA), has stepped down from her position. The federal agency confirmed her resignation on Thursday on social media platform X. This news comes just two days after the announcement of her appointment was made.

The U.S. Department of Health and Human Services (HHS), the umbrella organization overseeing the FDA, has since retracted the news of her appointment. The original announcement made on Tuesday has been removed from the official records. The reasons behind Perkins’ sudden resignation remain undisclosed.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.